Silk,
a natural biopolymer, has been used clinically as suture
material over thousands of years and has received much impetus for
a plethora of biomedical applications in the last two decades. Silk
protein isolated from both mulberry and nonmulberry silkworm varieties
gained recognition as a potential biomaterial owing to its affordability
and remarkable physicochemical properties. Molecular studies on the
amino acid composition and conformation of silk proteins interpreted
in the present review provide a critical understanding of the difference
in crystallinity, hydrophobicity, and tensile strength among silkworm
silk proteins. Meticulous silk fibroin (SF) isolation procedures and
innovative processing techniques to fabricate gamut of two-dimensional
(2D) and three-dimensional (3D) matrices including the latest 3D printed
scaffolds have led SF for diverse biomedical applications. Crucial
factors for clinical success of any biomaterial, including biocompatibility,
immune response, and biodegradability, are discussed with particular
emphasis on the lesser-known endemic nonmulberry silk varieties, which
in recent years have gained considerable attention. The tunable biodegradation
and bioresorbable attributes of SF enabled its use in drug delivery
systems, thus proving it as an efficient and specific vehicle for
controlled drug release and targeted drug delivery. Advancements in
fabrication methodologies inspired biomedical researchers to develop
SF-based in vitro tissue models mimicking the spatiotemporal
arrangement and cellular distribution of native tissue. In
vitro tissue models own a unique demand for studying tissue
biology, cellular crosstalks, disease modeling, drug designing, and
high throughput drug screening applications. Significant progress
in silk biomaterial research has evolved into several silk-based healthcare
products in the market. Insights of silk-based products assessed in
the human clinical trials are presented in this review. Overall, the
current review explores the paradigm of the silk structure–function
relationship driving silk-based biomaterials toward tissue engineering,
drug delivery systems, and in vitro tissue models.